Sunday, October 17, 2021

Lennox-Gastaut syndrome

FDA Declares Cannabis Drug Epidiolex No Longer A Controlled Substance

The stock was rising over 3% to lately trade at $85.06 on the news. This further lifts the stock from its 52-week low of $67.98.

You Should Reconsider Using Store-Bought CBD To Treat Seizures

In patients with rare forms of epilepsy, artisanal CBD increased seizures while pharmaceutical CBD caused seizure reduction.

Cannabis: Misinformation About CBD Can Be Life-Threatening

In a rush to praise the effectiveness of the cannabis plant, hyperbole can have long-ranging consequences for medical patients.

Marijuana’s CBD Can Help Sufferers Of Lennox–Gastaut Syndrome

A study published in the New England Journal of Medicine explored the potential for CBD combined with current medicine therapies to help patients with this severe form of epilepsy.

Marijuana-Based Epilepsy Drug Is Close To FDA Approval

A marijuana-based drug received a unanimous thumbs-up from a panel of experts organized by the Food and Drug Administration.

FOR A WEEKLY DOSE OF THE FRESH TOAST

Hand selected from our editors with all the latest news and entertainment with a side of cannabis.

Follow Us

123,000FansLike
7,000FollowersFollow
6,500FollowersFollow

Latest Articles